The Readout Loud

Episodes

• Episode 183: Greg Zuckerman on the vaccine race, plus Biogen's troubled launch

  Oct 21, 2021

  Not summarized yet

• Episode 182: The FDA star search, more booster debates, & the future of mRNA

  Oct 14, 2021

  Not summarized yet

• Episode 181: Brent Hodge on filming Shkreli, the next NIH director, and a looming FDA deadline

  Oct 7, 2021

  Not summarized yet

• Episode 180: Health equity 'tourism,' an $11B biopharma acquisition, & a bony Covid protest

  Sep 30, 2021

  Not summarized yet

• Episode 179: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm's slow rollout

  Sep 23, 2021

  Not summarized yet

• Episode 178: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial

  Sep 16, 2021

  Not summarized yet

• Episode 177: Bijan Salehizadeh on Covid tests, plus Verily's moment of truth

  Sep 9, 2021

  Not summarized yet

• Episode 176: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals

  Sep 2, 2021

  Not summarized yet

• Episode 175: Dorit Reiss on vaccine mandates, plus biotech's messy summer

  Aug 26, 2021

  Not summarized yet

• Episode 174: Biotech's trust issues, overwhelmed health workers, & the nuances of insider trading

  Aug 19, 2021

  Not summarized yet

• Episode 173: Biden's drug pricing plan, Wall Street's Alzheimer's fixation, & daily 5 a.m. alarms

  Aug 12, 2021

  Not summarized yet

• Episode 172: The mRNA gold rush, Delta's alarming rise, & the next treatment for Alzheimer's

  Aug 5, 2021

  Not summarized yet

• Episode 171: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screen

  Jul 29, 2021

  Not summarized yet

• Episode 170: Céline Gounder on breakthrough infections, plus the power of lobbying

  Jul 22, 2021

  Not summarized yet

• Episode 169: Dan Diamond on covering Biden, plus the FDA's future, & the latest Aduhelm twist

  Jul 15, 2021

  Not summarized yet

• Episode 168: Aduhelm's latest twist, & how Covid variants are shaping the summer

  Jul 8, 2021

  Not summarized yet

• Episode 167: George Yancopoulos on biotech in 2021, plus a CRISPR milestone, Biogen's FDA saga,

  Jul 1, 2021

  Not summarized yet

• Episode 166: FDA inner workings, GSK's foggy future, & the alarming rise in colorectal cancer

  Jun 24, 2021

  Not summarized yet

• Episode 165: Paul Offit on the Covid vaccine booster debate, & Robyn Karnauskas' call of the decade

  Jun 17, 2021

  Not summarized yet

• Episode 164: Every angle on the FDA's polarizing approval of Biogen's Alzheimer's drug

  Jun 10, 2021

  Not summarized yet